(Q54327084)

27 May 2018

title

Multielectrode Array (MEA) Assay for Profiling Electrophysiological Drug Effects in Human Stem Cell-Derived Cardiomyocytes. (English)

1 reference

27 May 2018

author name string

Mike Clements

series ordinal

1

1 reference

27 May 2018

publication date

4 May 2016

1 reference

27 May 2018

Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.]

published in

1 reference

27 May 2018

volume

68

1 reference

27 May 2018

page(s)

22.4.1-22.4.32

1 reference

27 May 2018

Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment

cites work

1 reference

Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes

21 January 2018

1 reference

Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes

21 January 2018

1 reference

CiPA: Ongoing testing, future qualification procedures, and pending issues

21 January 2018

1 reference

High-throughput multi-parameter profiling of electrophysiological drug effects in human embryonic stem cell derived cardiomyocytes using multi-electrode arrays.

21 January 2018

1 reference

Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment

21 January 2018

1 reference

Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.

21 January 2018

1 reference

New easy-to-use hybrid system for extracellular potential and impedance recordings

21 January 2018

1 reference

High-throughput cardiac safety evaluation and multi-parameter arrhythmia profiling of cardiomyocytes using microelectrode arrays

21 January 2018

1 reference

An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation

21 January 2018

1 reference

Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model

21 January 2018

1 reference

The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts

21 January 2018

1 reference

Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures.

21 January 2018

1 reference

Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays

21 January 2018

1 reference

CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia--effects of 7 reference compounds at 10 facilities.

21 January 2018

1 reference

MICE models: superior to the HERG model in predicting Torsade de Pointes

21 January 2018

1 reference

Alfuzosin delays cardiac repolarization by a novel mechanism

21 January 2018

1 reference

Rapid cellular phenotyping of human pluripotent stem cell-derived cardiomyocytes using a genetically encoded fluorescent voltage sensor

21 January 2018

1 reference

High Throughput Measurement of Ca++ Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A Cardiac Risk Assessment Characterization Using a Large Panel of Cardioactive and Inactive Compounds

21 January 2018

1 reference

Micro-electrode arrays in cardiac safety pharmacology: a novel tool to study QT interval prolongation

21 January 2018

1 reference

QT-screen: high-throughput cardiac safety pharmacology by extracellular electrophysiology on primary cardiac myocytes

21 January 2018

1 reference

Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk

21 January 2018

1 reference

Screening drug-induced arrhythmia [corrected] using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays

21 January 2018

1 reference

Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation

21 January 2018

1 reference

Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: Qualitative effects on electrophysiological responses to drugs

21 January 2018

1 reference

The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes

21 January 2018

1 reference

Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform

21 January 2018

1 reference

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

21 January 2018

1 reference

Effect of cardioactive drugs on action potential generation and propagation in embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

The electrocardiogram of human embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach.

21 January 2018

1 reference

Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells

21 January 2018

1 reference

Biological application of microelectrode arrays in drug discovery and basic research.

21 January 2018

1 reference

In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

A miniature microelectrode array to monitor the bioelectric activity of cultured cells.

21 January 2018

1 reference

Low-density plating is sufficient to induce cardiac hypertrophy and electrical remodeling in highly purified human iPS cell-derived cardiomyocytes

21 January 2018

1 reference

Heart on a Chip — Extracellular Multielectrode Recordings from Cardiac Myocytes in Vitro

21 January 2018

1 reference

7 January 2021

Utility of hERG assays as surrogate markers of delayed cardiac repolarization and QT safety

1 reference

7 January 2021

High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction

1 reference

7 January 2021

Evolution of action potential propagation and repolarization in cultured neonatal rat ventricular myocytes

1 reference

7 January 2021

https://api.fatcat.wiki/v0/release/bpoznjdavrczbm27n5wmv7ccc4

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_bpoznjdavrczbm27n5wmv7ccc4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bpoznjdavrczbm27n5wmv7ccc4

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/bpoznjdavrczbm27n5wmv7ccc4

1 reference

30 July 2022